Emerald Health Sciences Inc.
SEC CIK 1728413 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SKYE | Skye Bioscience, Inc. | 10% | 169.41M | — | — | 1 | 2023-02-22 | 2023-02-22 |
Most active insiders at SKYE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | 5AM Partners VII, LLC | 10% | — | $444.6K |
| 2 | Schwab Andrew J. | Dir, 10% | — | $444.6K |
| 3 | DHILLON PUNIT | CEO, Dir | — | — |
Emerald Health Sciences Inc. made no open-market trades at SKYE in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-17 | 2023-02-22 | SKYE | Skye Bioscience, Inc. | Emerald Health Sciences Inc. | 10% | A - Grant | $0.0343 | +58.02M | 169.41M | +52% | +$1.99M |
Purchase Sale Sale after option exercise All abbreviations